Honorable Stephanie Klick, Chair, House Committee on Public Health
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
HB1164 by Oliverson (Relating to the designation of centers of excellence for the management and treatment of placenta accreta spectrum disorder.), As Introduced
Estimated Two-year Net Impact to General Revenue Related Funds for HB1164, As Introduced : a negative impact of ($387,624) through the biennium ending August 31, 2023.
The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
General Revenue-Related Funds, Five- Year Impact:
Fiscal Year
Probable Net Positive/(Negative) Impact to General Revenue Related Funds
2022
($191,062)
2023
($196,562)
2024
($196,914)
2025
($197,276)
2026
($197,650)
All Funds, Five-Year Impact:
Fiscal Year
Probable Savings/(Cost) from General Revenue Fund 1
Change in Number of State Employees from FY 2021
2022
($191,062)
2.2
2023
($196,562)
2.0
2024
($196,914)
2.0
2025
($197,276)
2.0
2026
($197,650)
2.0
Fiscal Analysis
The bill would amend Chapter 32 of the Health and Safety Code to require the Department of State Health Services (DSHS), in consultation with the Texas Maternal Mortality and Morbidity Review Committee, to designate health care entities or programs as centers of excellence for the management and treatment of placenta accreta spectrum disorder. The bill would require DSHS to appoint a subcommittee to the review committee to advise the Health and Human Services Commission (HHSC) on the development of rules related to the designation of centers of excellence. HHSC would be required to develop rules and DSHS would be required to begin awarding designations by September 1, 2022.
Methodology
According to DSHS, the agency would need 2.0 full-time equivalents (FTEs) to implement and manage a program to designate centers of excellence for the management and treatment of placenta accreta spectrum disorder. This would include a nurse to participate in surveys, complaint investigations, and complete reports regarding the designated centers of excellence and a program specialist to coordinate the designation program and provide technical assistance.
HHSC indicated that any costs associated with implementing the provisions of the bill could be absorbed within existing resources.
Technology
The analysis assumes there would be technology costs related to staff augmentation of 0.2 FTEs in fiscal year 2022 to update the Regulatory Automation System. There would also be FTE-related costs including seat management, data center services, and software licenses. The total technology costs would be $28,044 in fiscal year 2022 and $10,910 in later years.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies:
529 Hlth & Human Svcs Comm, 537 State Health Services